Download PDF
CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2013; 34(03): 175-176
DOI: 10.4103/0971-5851.123721
ORIGINAL ARTICLE

Report of chronic myeloid leukemia in chronic phase from Eastern India, Institute of Hematology and Transfusion Medicine, Kolkata, 2001-2009

Siddhartha Sankar Ray
Department of Hematology, Institute of Haematology and Transfusion Medicine, Medical College, Kolkata, West Bengal, India
,
Prantar Chakraborty
Department of Hematology, Institute of Haematology and Transfusion Medicine, Medical College, Kolkata, West Bengal, India
,
Utpal Chaudhuri
Department of Hematology, Institute of Haematology and Transfusion Medicine, Medical College, Kolkata, West Bengal, India
,
Ganesh › Author Affiliations
› Further Information
  PDF Download Permissions and Reprints

Abstract

The data 192 patients from Eastern India, Kolkata center was presented in Indian cooperative oncology network meeting, out of which 97% patients were diagnosed in the chronic phase. Complete hematological response was seen in 70.5% among patients and 86% of patients were in clinical and hematological remission over 5 years with a median follow-up of 4.85 years.

Keywords

Chronic myeloid leukemia - chronic phase - Institute of Hematology and Transfusion Medicine


Publication History

Article published online:
19 July 2021

© 2013. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Lee SJ. Chronic myelogenous leukaemia. Br J Haematol 2000;111:993-1009.
  • 2 Baccarani M, Cortes J, Pane F, Niederwieser D, Saglio G, Apperley J, et al. Chronic myeloid leukemia: An update of concepts and management recommendations of European LeukemiaNet. J Clin Oncol 2009;27:6041-51.
  • 3 Jabbour E, Cortes JE, Kantarjian HM. Suboptimal response to or failure of imatinib treatment for chronic myeloid leukemia: What is the optimal strategy? Mayo Clin Proc 2009;84:161-9.